Skip to content

Hepatitis C vaccine development shows progress but scientific barriers remain

Professor Andrea Cox of Johns Hopkins University presenting at INHSU 2016. Photo by Liz Highleyman, hivandhepatitis.com

Two booklets highly commended at BMA Patient Information Awards 2016

Two booklets highly commended at BMA Patient Information Awards 2016

Effective antiviral treatment reduces fatigue in people with chronic hepatitis C

Rasmus Thornhøj of Odense University Hospital presents findings from the FAT-HEP study. Photo by Liz Highleyman, hivandhepatitis.com

INHSU 2016 opens with focus on hepatitis C prevention and treatment for people who inject drugs

Holly Hagan of New York University presenting at INHSU 2016. Photo by Liz Highleyman, hivandhepatitis.com

Statins reduce risk of progression to cirrhosis in people with HIV/HCV co-infection

Improvements in HIV treatment and care have had no impact on rates of endstage liver disease among HIV-positive people with viral hepatitis

Many people in the US with chronic hepatitis B not being properly monitored

Neglect of infectious diseases in prisons highlighted at AIDS 2016

HIV not a risk factor for fibrosis progression in people with hepatitis C